New EU Submissions For Pfizer’s Lorlatinib, Teva’s Fremanezumab - And A CV Filing For Canakinumab

 
• By Ian Schofield
  
Review
Several products are newly under evaluation by the EMA

More from Product Reviews

More from Pink Sheet